Publication:
Biomarkers for atrial fibrillation and chronic kidney disease: What is the evidence?

Simple item page
dc.contributor.authorRungroj Krittayaphongen_US
dc.contributor.authorKomsing Methavigulen_US
dc.contributor.otherSiriraj Hospitalen_US
dc.contributor.otherCentral Chest Institute of Thailanden_US
dc.date.accessioned2022-08-04T09:09:24Z
dc.date.available2022-08-04T09:09:24Z
dc.date.issued2021-10-29en_US
dc.identifier.citationKardiologia Polska. Vol.79, No.10 (2021), 1058-1059en_US
dc.identifier.doi10.33963/KP.A2021.0124en_US
dc.identifier.issn18974279en_US
dc.identifier.issn00229032en_US
dc.identifier.other2-s2.0-85119267382en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/77759
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85119267382&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleBiomarkers for atrial fibrillation and chronic kidney disease: What is the evidence?en_US
dc.typeEditorialen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85119267382&origin=inwarden_US

Files

Collections

Scopus 2021